Limitations of Current Biomarkers in Assessing Post-Pregnancy Heart Failure Risk
New research questions the effectiveness of traditional biomarkers like NT-proBNP for predicting heart failure in women after complicated pregnancies, emphasizing the need for new screening methods.
Recent research indicates that the biomarkers traditionally used to predict heart failure risk may not be effective for women following complicated pregnancies, such as those affected by hypertension or diabetes. A study published in JAMA Cardiology analyzed over 4,000 pregnancies across various medical centers, focusing on NT-proBNP, a common biomarker for heart failure. While approximately 1 in 17 women exhibited elevated levels of NT-proBNP years after childbirth — suggesting cardiac stress — pregnancies with conditions like preeclampsia, hypertension, or gestational diabetes did not show a corresponding increase in this biomarker. Contrary to expectations, women with these pregnancy complications tended to have lower levels of NT-proBNP, which challenges its reliability in postpartum cardiovascular screening.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds Weighted Vests May Support Weight Loss in Older Adults Without Preventing Bone Loss
Research reveals that weighted vests and resistance training do not prevent bone loss in older adults during weight loss, highlighting the need for combined strategies to protect skeletal health.
Inconsistent Outcomes of Oxytocin Therapy for Social Behaviors: Insights from Neuroscience Research
Research reveals that oxytocin's effectiveness in improving social behaviors varies depending on brain activity and individual motivation, emphasizing the need for personalized treatment approaches.
